1

2
Kandasamy Hariharan, Nabil Hanna, Gary R Braslawsky, Nuzhat Pathan: Use of CD23 Antagonists for the Treatment of Neoplastic Disorders. Biogen Idec, Pillsbury Winthrop Shaw Pittman, December 21, 2006: US20060286101-A1

Methods and kits for the treatment of neoplastic disorders comprising the use of a CD23 antagonist are provided. The CD23 antagonist may be used alone or in combination with chemotherapeutic agents. In particularly preferred embodiments the CD23 antagonists may be used to treat B cell chronic lympho ...


3
Kandasamy Hariharan, Nabil Hanna, Gary R Braslawsky, Nuzhat Pathan: Use of CD23 antagonists for the treatment of neoplastic disorders. Pillsbury Winthrop, November 13, 2003: US20030211107-A1

Methods and kits for the treatment of neoplastic disorders comprising the use of a CD23 antagonist are provided. The CD23 antagonist may be used alone or in combination with chemotherapeutic agents. In particularly preferred embodiments the CD23 antagonists may be used to treat B cell chronic lympho ...


4
Kandasamy Hariharan, Nabil Hanna, Gary R Braslawsky, Nuzhat Pathan: Use of cd23 antagonists for the treatment of neoplastic disorders. Biogen Idec, Pillsbury Winthrop Shaw Pittman, September 4, 2008: US20080213260-A1

Methods and kits for the treatment of neoplastic disorders comprising the use of a CD23 antagonist are provided. The CD23 antagonist may be used alone or in combination with chemotherapeutic agents. In particularly preferred embodiments the CD23 antagonists may be used to treat B cell chronic lympho ...


5
Kandasamy Hariharan, Nabil Hanna, Gary R Braslawsky, Nuzhat Pathan: Use of cd23 antagonists for the treatment of neoplastic disorders. Biogen Idec, Pillsbury Winthrop Shaw Pittman, September 4, 2008: US20080213167-A1

Methods and kits for the treatment of neoplastic disorders comprising the use of a CD23 antagonist are provided. The CD23 antagonist may be used alone or in combination with chemotherapeutic agents. In particularly preferred embodiments the CD23 antagonists may be used to treat B cell chronic lympho ...


6
Kandasamy Hariharan, Nabil Hanna, Gary R Braslawsky, Nuzhat Pathan: Use of cd23 antagonists for the treatment of neoplastic disorders. Biogen Idec, Pillsbury Winthrop Shaw Pittman, September 4, 2008: US20080213168-A1

Methods and kits for the treatment of neoplastic disorders comprising the use of a CD23 antagonist are provided. The CD23 antagonist may be used alone or in combination with chemotherapeutic agents. In particularly preferred embodiments the CD23 antagonists may be used to treat B cell chronic lympho ...


7
Kandasamy Hariharan, Nabil Hanna, Gary Braslawsky, Nuzhat Pathan: Use of CD23 antagonists for the treatment of neoplastic disorders. Pillsbury Winthrop, October 31, 2002: US20020159996-A1

Methods and kits for the treatment of neoplastic disorders comprising the use of a CD23 antagonist are provided. The CD23 antagonist may be used alone or in combination with chemotherapeutic agents. In particularly preferred embodiments the CD23 antagonists may be used to treat B cell chronic lympho ...


8
Kandasamy Hariharan, Nabil Hanna, Gary R Braslawsky, Nuzhat Pathan: Use of cd23 antagonists for the treatment of neoplastic disorders. Biogen Idec, Pillsbury Winthrop Shaw Pittman, July 17, 2008: US20080171056-A1

Methods and kits for the treatment of neoplastic disorders comprising the use of a CD23 antagonist are provided. The CD23 antagonist may be used alone or in combination with chemotherapeutic agents. In particularly preferred embodiments the CD23 antagonists may be used to treat B cell chronic lympho ...


9
Kandasamy Hariharan, Nabil Hanna, Gary R Braslawsky, Nuzhat Pathan: Use of cd23 antagonists for the treatment of neoplastic disorders. Biogen Idec, Pillsbury Winthrop Shaw Pittman, August 3, 2006: US20060171950-A1

Methods and kits for the treatment of neoplastic disorders comprising the use of a CD23 antagonist are provided. The CD23 antagonist may be used alone or in combination with chemotherapeutic agents. In particularly preferred embodiments the CD23 antagonists may be used to treat B cell chronic lympho ...


10